Explained: Guillain-Barré and vaccines - What you need to know
Top Searches
Explained: Guillain-Barré and vaccines - What you need to know
Emily Anthes / NYT News Service / Jul 13, 2021, 09:20 IST
FacebookTwitterLinkedinEMail
A doctor fills a syringe with the Johnson & Johnson Covid-19 vaccine (File photo)
Johnson & Johnson’s beleaguered Covid-19 vaccine may be associated with a small increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition, federal officials said Monday. The Food and Drug Administration has added a warning about the potential side effect to its fact sheets about the vaccine.
The risk appears to be very small. So far, there have been 100 reports of the syndrome in people who had received the Johnson & Johnson vaccine. Nearly 13 million doses of the vaccine have been administered in the United States.